Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

I B Hirsch

Showing results (31-40 of 60) with videos related to

Pageof 6
Sort By:
Diabetic Medicine : a Journal of the British Diabetic Association|July 31, 2019
What is innovation in the area of medicines? The example of insulin and diabetesD Beran, I B Hirsch, J S Yudkin
JAMA|May 30, 1998
Insulin treatment for type 2 diabetesI B Hirsch, T C Evans, B Gaster
Diabetes Care|December 1, 1990
Intensive insulin therapy for treatment of type I diabetesI B Hirsch, R Farkas-Hirsch, J S Skyler
Archives of Internal Medicine|February 24, 1998
Cushing syndrome due to surreptitious glucocorticoid administrationS Quddusi, P Browne, B Toivola, et al.
The American Journal of Physiology|February 1, 1996
Effect of stepped hypoglycemia on regional cerebral blood flow response to physiological brain activationW J Powers, I B Hirsch, P E Cryer
Clinical Science (London, England : 1979)|June 1, 1991
Increased symptoms of hypoglycaemia in the standing position in insulin-dependent diabetes mellitusI B Hirsch, S R Heller, P E Cryer
Diabetes Care|April 1, 1992
Catheter obstruction with continuous subcutaneous insulin infusion. Effect of insulin concentrationI B Hirsch, R Farkas-Hirsch, J B McGill
Diabetes|August 1, 1994
Reduced plasma peroxyl radical trapping capacity and increased susceptibility of LDL to oxidation in poorly controlled IDDME C Tsai, I B Hirsch, J D Brunzell, et al.
Diabetic Medicine : a Journal of the British Diabetic Association|January 17, 2016
Safety and efficacy of insulin degludec/insulin aspart with bolus mealtime insulin aspart compared with standard basal-bolus treatment in people with Type 1 diabetes: 1-year results from a randomized clinical trial (BOOST<sup>®</sup> T1)I B Hirsch, E Franek, H Mersebach, et al.
Archives of Internal Medicine|April 10, 1995
Long QT syndrome during high-dose cisaprideS Bran, W A Murray, I B Hirsch, et al.
Pageof 6

Showing results (31-40 of 60) with videos related to

Sort By:
Pageof 6
Diabetic Medicine : a Journal of the British Diabetic Association|July 31, 2019
What is innovation in the area of medicines? The example of insulin and diabetesD Beran, I B Hirsch, J S Yudkin
JAMA|May 30, 1998
Insulin treatment for type 2 diabetesI B Hirsch, T C Evans, B Gaster
Diabetes Care|December 1, 1990
Intensive insulin therapy for treatment of type I diabetesI B Hirsch, R Farkas-Hirsch, J S Skyler
Archives of Internal Medicine|February 24, 1998
Cushing syndrome due to surreptitious glucocorticoid administrationS Quddusi, P Browne, B Toivola, et al.
The American Journal of Physiology|February 1, 1996
Effect of stepped hypoglycemia on regional cerebral blood flow response to physiological brain activationW J Powers, I B Hirsch, P E Cryer
Clinical Science (London, England : 1979)|June 1, 1991
Increased symptoms of hypoglycaemia in the standing position in insulin-dependent diabetes mellitusI B Hirsch, S R Heller, P E Cryer
Diabetes Care|April 1, 1992
Catheter obstruction with continuous subcutaneous insulin infusion. Effect of insulin concentrationI B Hirsch, R Farkas-Hirsch, J B McGill
Diabetes|August 1, 1994
Reduced plasma peroxyl radical trapping capacity and increased susceptibility of LDL to oxidation in poorly controlled IDDME C Tsai, I B Hirsch, J D Brunzell, et al.
Diabetic Medicine : a Journal of the British Diabetic Association|January 17, 2016
Safety and efficacy of insulin degludec/insulin aspart with bolus mealtime insulin aspart compared with standard basal-bolus treatment in people with Type 1 diabetes: 1-year results from a randomized clinical trial (BOOST<sup>®</sup> T1)I B Hirsch, E Franek, H Mersebach, et al.
Archives of Internal Medicine|April 10, 1995
Long QT syndrome during high-dose cisaprideS Bran, W A Murray, I B Hirsch, et al.
Pageof 6